Recombinant CA 19-9 抗体
Quick Overview for Recombinant CA 19-9 抗体 (ABIN4949235)
抗原
See all CA 19-9 抗体抗体类型
适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
纯化方法
- Protein A affinity
-
免疫原
- Purified human protein used as the immunogen for the recombinant CA19-9 antibody.
-
亚型
- IgG kappa
-
-
-
-
应用备注
-
Optimal dilution of the recombinant CA19-9 antibody should be determined by the researcher.
1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.\. Flow Cytometry: 2-4 μg/million cells in 0.1ml,Immunofluorescence: 5-10 μg/mL,Immunohistochemistry (FFPE): 5-10 μg/mL for 30 min at RT,Prediluted IHC only format: incubate for 30 min at RT (1)
-
限制
- 仅限研究用
-
-
-
浓度
- 1 mg/mL
-
缓冲液
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
储存液
- Azide free
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Store the recombinant CA19-9 antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
-
-
- CA 19-9 (Gastrointestinal Cancer Antigen CA19-9 (CA 19-9))
-
别名
- CA19-9
-
背景
- CA19-9, a carbohydrate epitope expressed on a high MW (>400 kDa) mucin glycoprotein, is a sialyl Lewisa structure which is synthesized from type 1 blood group precursor chains and is present in individuals expressing the Lewisa and/or Lewisb blood group antigens.
抗原
-